The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
TransMedics Group, Inc(NASDAQ:TMDX) 
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring...
Website: http://www.transmedics.com
Founded: 1998
Full Time Employees: 109
CEO: Waleed H. Hassanein
Sector: Healthcare
Industry: Medical Devices
TransMedics Group Number of Twitter Followers
TransMedics Group Management Fiscal Year Revenue Guidance High/Low
TransMedics Group Job Openings
TransMedics Group Days Payable Outstanding ttm (DPO)
TransMedics Group Days Receivable Outstanding ttm (DSO)
TransMedics Group Days Inventory Outstanding ttm (DIO)
TransMedics Group Op Cashflow Per Share ttm
TransMedics Group Free Cashflow Per Share ttm
TransMedics Group Cash Per Share ttm
TransMedics Group P/S ratio ttm
TransMedics Group (GAAP) P/E ratio ttm
TransMedics Group P/B ratio ttm
No extra charts and metrics for this ticker.